- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT05838911
Esito della riabilitazione polmonare per i pazienti con grave malattia polmonare cronica ostruttiva sottoposti a stimolazione elettrica neuromuscolare (NEMS for COPD)
Background: Patients with COPD often experience skeletal muscle dysfunction. For those who are unable or unwilling to undertake physical training, neuromuscular electrical stimulation (NMES) may provide an alternative method of exercise training.
Objective: To investigate the effects of adding neuromuscular electrical stimulation of gluteus maximus, quadriceps and calf muscles to chest physiotherapy, compared to chest physiotherapy alone, on muscle strength (gluteus max., quadriceps, calf muscles), femoral blood flow physical and pulmonary function in severe COPD Patients.
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Material and methods: This study include a group of 60 patients (30 males and 30 females) diagnosed with severe COPD), their age is ranged 65-75 years, they will be randomly divided into two groups; study group (A) 30 patients and study group (B) 30 patients. Study group (A): The patients in this group will receive the chest physiotherapy program for 20 min each day, for five days a week for 8 consecutive weeks. Study group (B): The patients in this group will receive the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, calf muscles, performed for 30 min /day for five days a week for 8 consecutive weeks. Femoral blood Flow, gluteus maximus, quadriceps and calf muscles strength and pulmonary function (FEV1/FVC) will be measured for both groups pre and post-treatment, then after 3 months follow up.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
-
Qina, Egitto
- Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- A diagnosis of COPD with FEV1/FVC <50% predicted as per the GOLD guidelines.
- Self-reported dyspnea and/or arm fatigue during at least one activity of daily living that required arm exercise.
- Dyspnea and/or physical activity fatigue were self-reported by the Borg Scale.
- Before entering in the study, all patients had their pulmonary function optimized with long-acting bronchodilators and corticosteroids.
Exclusion Criteria:
-
• Patients with unstable angina pectoris.
- Progressive ventricular dysrhythmia.
- Intermittent claudication.
- Implanted cardiac pacemakers.
- Uncontrolled diabetes mellitus.
- Peripheral vascular disease.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Doppio
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Control Group
The patients in this group were received the chest physiotherapy program for 20 min each day, for five days a week for8 consecutive weeks. |
The patients in this group were received the chest physiotherapy program for 20 min each day, for five days a week for 8 consecutive weeks
Altri nomi:
|
|
Sperimentale: Study Group
The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation (NMES) of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for 8 consecutive weeks. |
The patients in this group were received the same chest physiotherapy program combined with neuromuscular electrical stimulation of gluteus max., quadriceps, and calf muscles performed for 30 min /day for five days a week for 8 consecutive weeks.
Altri nomi:
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Six-minute walking test (Physical function assessment
Lasso di tempo: change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
The six-minute walking distance (6MWD) was measured according to a standardized protocol.
|
change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
|
Pulmonary function test
Lasso di tempo: change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
Pulmonary capacity and respiratory muscle functions will be assessed using the CPFS/D USB™ 187 Spirometer (Medical Graphics-MGC, St. Paul, MN, USA) with airflow being measured by a 188 calibrated Pitot tube (PreVent, Pneumotach). The participant completed at least three acceptable maximal forced and slow expiratory maneuvers after 15 min the inhalation of 400 mg of salbutamol 190 via a metered-dose inhaler. Forced vital capacity (FVC, L), forced expiratory volume in one second (FEV1, L), FEV1/ FVC, and inspiratory capacity (IC) will be measured according to American Thoracic Society standards |
change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
|
Muscle strength measurement
Lasso di tempo: change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
To determine the maximal muscle strength the Lafayette manual muscle test system (USER MANUAL) (MMT) Model 01163, White Plains, New York (10602) of gluteus maximus, quadriceps and calf muscles will be measured on right lower limb. |
change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Blood flow velocimetry measurement
Lasso di tempo: change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
To evaluate changes in peripheral perfusion. The standard pulsed-wave Doppler velocimetry of the right femoral artery was performed using sonos 2000 echograph (Philips Envisor ) |
change from baseline to 8 weeks after intervention and 3 months as a follow-up
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Direttore dello studio: Ibrahim I. I Abu zaid, PhD, Department of P.T for internal medicine, Faculty of Physical Therapy, South valley university, Qena, Egypt
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- BeniSuefU_1
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .